Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress. Nyquist et al.

These are the uncropped western blots used in figures 3 and 4

本数据集包含用于图3和图4中的未裁剪的蛋白质印迹图像。